WATERTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (NASDAQ:HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer, today announced that management will participate in the following upcoming investor conferences in the month of September:
H.C. Wainwright Annual Global Investor Conference
Date: Monday, September 11
Time: 12:30pm ET
Location: New York
Management will participate in a fireside chat.
Cantor Fitzgerald Global Healthcare Conference 2023
Date/Time: Wednesday, September 27
Time: 3:35pm ET
Location: New York, ...